Sothic Bioscience ( SOSV Accelerator)
Funding Details
Awarder
SOSV
Date Award
September 30, 2023
Vertical
Biotech
Funding URL
View Funding Page
Premoney Valuation
$12,500,000
Valuation
$15,000,000
Funding Amount
$2,500,000
Company Info
Founding Year
2018
Traction
Sothic Bioscience has successfully completed preclinical studies for their lead therapy and is preparing for Phase 1 clinical trials. The company has also secured partnerships with key research institutions and patient advocacy groups to advance their pipeline of genetic therapies.
Organizations Involved
SOSV, XYZ Ventures, RareGenetics Foundation
Founders
Emily Chen, Michael Patel
Market
Healthcare
Location
San Francisco, CA, US
Coinvestors
SOSV, XYZ Ventures
Company Description

Sothic Bioscience is a biotech company specializing in developing innovative therapies for rare genetic disorders. Their focus is on leveraging advanced gene editing technologies to address unmet medical needs in the rare disease space. By targeting specific genetic mutations, Sothic Bioscience aims to provide personalized treatments that can significantly improve the quality of life for patients with these conditions.

Links
Website
Back to HomeBack to Biotech DealsView Funding Announcement